DEVONN BOURG: Open Payments
NPI 1467919928 · MILTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,225 in 50 payments from 16 companies in 2025. Trend: 2023 $103 · 2024 $706 · 2025 $1,225
Food & beverage: $1,225
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $350 |
| ABBVIE INC. | 7 | $184 |
| Axsome Therapeutics, Inc. | 3 | $144 |
| Phathom Pharmaceuticals, Inc. | 2 | $124 |
| Otsuka America Pharmaceutical, Inc. | 5 | $108 |
| Biosense Webster, Inc. | 2 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $43 |
| Amgen Inc. | 2 | $32 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
Products named: Ozempic, VRAYLAR, Symbravo, VOQUEZNA, Wegovy, REXULTI, CARTO 3, JARDIANCE.
Industry payments across FL — which companies pay providers there.
